JLJaebum Lee

Jaebum Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jaebum Lee has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Cristiano Susin

    Laboratory for Applied Periodontal and Craniofacial Regeneration (LAPCR)

    2 shared publications
  • Ulf M. E. Wikesjö

    Laboratory for Applied Periodontal and Craniofacial Regeneration (LAPCR)

    2 shared publications
  • Carlo Alberto Cortella

    Laboratory for Applied Periodontal and Craniofacial Regeneration (LAPCR)

    1 shared publication
  • Giuseppe Polimeni

    Laboratory for Applied Periodontal and Craniofacial Regeneration (LAPCR)

    1 shared publication
  • Håkan Lindström

    Product Development, Nobel Biocare AB, Göteborg, Sweden

    1 shared publication
  • Jan Hall

    Research and Development, Nobel Biocare AB, Göteborg, Sweden

    1 shared publication

Latest Publications

  • Evaluation of implants coated with rhBMP‐2 using two different coating strategies: a critical‐size supraalveolar peri‐implant defect study in dogs

    by Jaebum Lee, John F. Decker, Giuseppe Polimeni, Carlo Alberto Cortella, Michael D. Rohrer, John M. Wozney, Jan Hall, Cristiano Susin, Ulf M. E. Wikesjö

    Lee J, Decker JF, Polimeni G, Cortella CA, Rohrer MD, Wozney JM, Hall J, Susin C, Wikesjö UME. Evaluation of implants coated with rhBMP‐2 using two different coating strategies: a critical‐size supraalveolar peri‐implant defect study in dogs. J Clin Periodontol 2010; 37: 582–590. doi: 10.1111/j.1600‐051X.2010.01557.x. Background: Implants coated with recombinant human bone morphogenetic protein‐2 (rhBMP‐2) induce relevant bone formation but also resident bone remodelling.Objectives: To compare the effect of implants fully or partially coated with rhBMP‐2 on new bone formation and resident bone remodelling.Materials and Methods: Twelve, male, adult, Hound Labrador mongrel dogs were used. Critical‐size, supraalveolar, peri‐implant defects received titanium porous oxide surface implants coated in their most coronal aspect with rhBMP‐2 (coronal‐load/six animals) or by immersion of the entire implant in an rhBMP‐2 solution (soak‐load/six animals) for a total of 30 μg rhBMP‐2/implant. All implants were air‐dried. The animals were euthanized at 8 weeks for histometric evaluation.Results: Clinical healing was uneventful. Supraalveolar bone formation was not significantly affected by the rhBMP‐2 application protocol. New bone height and area averaged (± SE) 3.4 ± 0.2 versus 3.5 ± 0.4 mm and 2.6 ± 0.4 versus 2.5 ± 0.7 mm2 for coronal‐load and soak‐load implants, respectively (p>0.05). The corresponding bone density and bone–implant contact (BIC) recordings averaged 38.0 ± 3.8%versus 34.4 ± 5.6% and 25.0 ± 3.8%versus 31.2 ± 3.3% (p>0.05). In contrast, resident bone remodelling was significantly influenced by the rhBMP‐2 application protocol. Bone density outside the implants threads averaged 74.7 ± 3.8% and 50.8 ± 4.1% for coronal‐load and soak‐load implants, respectively (ppConclusion: Local application of rhBMP‐2 appears to be a viable technology to support local bone formation and osseointegration. Coronal‐load implants obviate resident bone remodelling without compromising new bone formation.


  • Evaluation of nano‐technology‐modified zirconia oral implants: a study in rabbits

    by Jaebum Lee, Janet H. Sieweke, Nancy A. Rodriguez, Peter Schüpbach, Håkan Lindström, Cristiano Susin, Ulf M. E. Wikesjö

    Objective: The objective of this study was to screen candidate nano‐technology‐modified, micro‐structured zirconia implant surfaces relative to local bone formation and osseointegration.Materials and Methods: Proprietary nano‐technology surface‐modified (calcium phosphate: CaP) micro‐structured zirconia implants (A and C), control micro‐structured zirconia implants (ZiUnite™), and titanium porous oxide implants (TiUnite™) were implanted into the femoral condyle in 40 adult male New Zealand White rabbits. Each animal received one implant in each hind leg; thus, 20 animals received A and C implants and 20 animals received ZiUnite™ and TiUnite™ implants in contralateral hind legs. Ten animals/group were euthanized at weeks 3 and 6 when biopsies of the implant sites were processed for histometric analysis using digital photomicrographs produced using backscatter scanning electron microscopy.Results: The TiUnite™ surface demonstrated significantly greater bone–implant contact (BIC) (77.6±2.6%) compared with the A (64.6±3.6%) and C (62.2±3.1%) surfaces at 3 weeks (p0.05). Similarly, there were non‐significant differences between the TiUnite™ and the ZiUnite™ surfaces (p>0.05). At 6 weeks, there were no significant differences in BIC between the TiUnite™ (67.1±4.2%), ZiUnite™ (69.7±5.7%), A (68.6±1.9%), and C (64.5±4.1%) surfaces (p>0.05).Conclusion: TiUnite™ and ZiUnite™ implant surfaces exhibit high levels of osseointegration that, in this model, confirm their advanced osteoconductive properties. Addition of CaP nano‐technology to the ZiUnite™ surface does not enhance the already advanced osteoconductivity displayed by the TiUnite™ and ZiUnite™ implant surfaces.